ASRS
DNLI icon

Arizona State Retirement System’s Denali Therapeutics DNLI Stock Holding History

Arizona State Retirement System’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$957K Sell
37,196
-957
-3% -$19.7K ﹤0.01% 1198
2026
Q1 		$733K Sell
38,153
-492
-1% -$9.79K ﹤0.01% 1272
2025
Q4 		$638K Sell
38,645
-2,168
-5% -$36.6K ﹤0.01% 1343
2025
Q3 		$593K Buy
40,813
+2,699
+7% +$38.8K ﹤0.01% 1406
2025
Q2 		$533K Buy
38,114
+1,002
+3% +$14.1K ﹤0.01% 1416
2025
Q1 		$505K Sell
37,112
-283
-0.8% -$5.42K ﹤0.01% 1417
2024
Q4 		$762K Buy
37,395
+438
+1% +$11.2K ﹤0.01% 1268
2024
Q3 		$1.08M Buy
36,957
+3,843
+12% +$95.3K 0.01% 1061
2024
Q2 		$769K Buy
33,114
+2,730
+9% +$52.4K 0.01% 1180
2024
Q1 		$623K Sell
30,384
-349
-1% -$6.56K ﹤0.01% 1311
2023
Q4 		$660K Sell
30,733
-448
-1% -$8.87K 0.01% 1293
2023
Q3 		$643K Buy
31,181
+469
+2% +$11.9K 0.01% 1236
2023
Q2 		$906K Buy
30,712
+3,166
+11% +$89K 0.01% 1077
2023
Q1 		$635K Buy
27,546
+3,182
+13% +$87.6K 0.01% 1278
2022
Q4 		$678K Buy
24,364
+976
+4% +$29K 0.01% 1198
2022
Q3 		$718K Buy
23,388
+221
+1% +$7.18K 0.01% 1116
2022
Q2 		$682K Buy
23,167
+1,709
+8% +$44.8K 0.01% 1183
2022
Q1 		$690K Buy
21,458
+178
+0.8% +$6.13K 0.01% 1284
2021
Q4 		$949K Sell
21,280
-178
-0.8% -$8.43K 0.01% 1132
2021
Q3 		$1.08M Buy
21,458
+270
+1% +$15.2K 0.01% 1037
2021
Q2 		$1.66M Sell
21,188
-1,502
-7% -$92.9K 0.01% 824
2021
Q1 		$1.3M Buy
22,690
+270
+1% +$18.1K 0.01% 954
2020
Q4 		$1.88M Sell
22,420
-1,484
-6% -$89.7K 0.02% 716
2020
Q3 		$856K Buy
23,904
+6,058
+34% +$182K 0.01% 997
2020
Q2 		$432K Buy
17,846
+3,192
+22% +$75K 0.01% 1202
2020
Q1 		$257K Buy
+14,654
New +$306K ﹤0.01% 1378

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's DNLI Position: Q2 2026 in Review

Arizona State Retirement System reduced its Denali Therapeutics (DNLI) stake by 2.5% in Q2 2026, selling an estimated $19.7K and leaving 37,196 shares worth $957K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Arizona State Retirement System first reported a position in DNLI in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.88M in Q4 2020. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Arizona State Retirement System held 37,196 shares of Denali Therapeutics worth $957K as of Q2 2026.
  • Arizona State Retirement System sold 957 Denali Therapeutics shares in Q2 2026, an estimated $19.7K.
  • Denali Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1198 holding.
  • Arizona State Retirement System first reported a position in Denali Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Denali Therapeutics position peaked at $1.88M in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.